Skip to content

The European Union Falsified Medicines Directive (FMD) is designed to protect public health by securing the pharmaceutical supply chain against counterfeit medicines. It’s a rigorous set of rules that pharmaceutical companies operating in Europe need to abide by, and at Sharp we can help.

Our comprehensive serialisation service can help you meet the criteria demanded by the FMD by making your products fully traceable and trackable through their supply chain.

We’re able to aggregate serial numbers for up to five levels of packaging in multiple formats, from the cavities of our blister packs through to the pallets they ship in, so you’ll always be able to identify where your products are – and where they came from.

Related Resources

We're proud to support International Day of Persons with Disabilities today to help increase awareness, understanding and acceptance of people with disabilities.
#TheFutureIsAccessible #IDPWD2019

Are you attending #OCTEastAsia next week?
Don’t miss the opportunity to meet our experts Deb Williams and Olivier Cena at stand 25. Explore Sharp’s capabilities in #drugdevelopment, #clinicalmanufacturing, #packaging, #IRT, #storage & #distribution.

#CTSEA19 #OCTEA19

Let's talk at #OCTEastAsia next week! Connect with the Sharp team at stand 25.
@ArenaIntOCT #OCTEastAsia #CTSEA19 #OCTEA19